• Image for Owning HIV: Young adults & the fight ahead
  • Image for Over 30 Years: The Mectizan® Donation Program
  • Ken Frazier
  • Image for After a tragic accident, healing the invisible wounds
Next story:
Health awareness Owning HIV: Young adults & the fight ahead

Learn more

Responsibility Over 30 Years: The Mectizan® Donation Program

Learn more

Responsibility Merck publishes 2019/2020 corporate responsibility report

Read Ken's letter

Our people After a tragic accident, healing the invisible wounds

Meet Geralyn

Next
  • Image for Owning HIV: Young adults & the fight ahead
  • Image for Over 30 Years: The Mectizan® Donation Program
  • Ken Frazier
  • Image for After a tragic accident, healing the invisible wounds

We invent for life

We're following the science to tackle some of the world's greatest health threats. But don't take it from us – see what our people and patients say.

Image for Lessons from dual pandemics

Lessons from dual pandemics

A conversation with Merck Chief Patient Officer Julie Gerberding, M.D., M.P.H., about her early work caring for people with HIV and AIDS, and the parallels of the AIDS and COVID-19 pandemics
Image for From isolation to empowerment: Stories from the HIV community
Patients

From isolation to empowerment: Stories from the HIV community

We sat down with two advocates for the HIV community to learn about their journeys through diagnosis and depression
young blonde girl with mom in doctors office
Patients & caregivers

How can we support you?

Medical treatment can be stressful enough. If you can’t afford your prescribed medications, we may be able to help you.

Research & products

Where creativity meets research

We bring creative minds together to invent important medicines and vaccines. We stop at nothing to help save and improve lives.

Column one image
Corporate responsibility

Supporting the future of our business and the well-being of patients, people and communities around the world.

Column one image
Investor relations

Find our latest financials, events & presentations, news, stock information and investor contacts.